Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a -29.604% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a: CCCC(c1nnnn1C(C)(C)C)N1CCN(Cc2ccccc2OC)CC1.Cl
b: CCC(C)c1ccc(NC(=S)NC(C)C2CCCO2)cc1
c: CCCCN(CCCNC(=O)c1c(C)cc(=O)oc1C)c1ccccc1
Answer: a. CCCC(c1nnnn1C(C)(C)C)N1CCN(Cc2ccccc2OC)CC1.Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCC(c1nnnn1C(C)(C)C)N1CCN(Cc2ccccc2OC)CC1.Cl
CCCC(c1nnnn1C(C)(C)C)N1CCN(Cc2ccccc2OC)CC1.Cl
1-[1-(1-tert-butyltetrazol-5-yl)butyl]-4-[(2-methoxyphenyl)methyl]piperazine;hydrochloride